1Silverstein FE,Faich G,Goldstein JL,et al.Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis:the CLASS study:a randomized controlled trial[J].JAMA,2000,284 (10):1247-1255.
2Bombardier C,Laine L,Reicin A,et al.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis[J].N Engl J Med,2000,343 (21):1520 -1528.
3Huang JQ,Sridhar S,Hunt RH.Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease:a meta-analysis[J].Lancet,2002,359 (9300):14-22.
4Silverstein FE,Graham DY,Senior JR,et al.Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs[J].Ann Intern Med,1995,123:241-249.
5Hawkey CJ,Karrasch JA,Szczepanski L,et al.Omeprazol compared with misoprostol for ulcers associated with nonsteroidal antinflammatory drugs[J].New Engl J Med,1998,338 (11):727-734.
6Yeomans ND,Tulassay Z,Juhasz L,et al.A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs.Acid Suppression Trial:ranitidine versus omeprazole for NSAID-associated ulcer[J].N Engl J Med,1998,338(11):719 -726.
